Rxsight Inc (RXST)

Currency in USD
5.80
-0.98(-14.45%)
Closed·
5.91+0.11(+1.90%)
·
Unusual trading volume
Trading near 52-week Low
RXST is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.306.50
52 wk Range
5.3016.74
Key Statistics
Prev. Close
6.78
Open
6.21
Day's Range
5.3-6.5
52 wk Range
5.3-16.74
Volume
2.14M
Average Vol. (3m)
760.23K
1-Year Change
-61.0067%
Book Value / Share
6.7
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RXST Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.79
Upside
+68.72%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Rxsight Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
6 Hold
2 Sell
Ratings:
9 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 9.79
(+68.72% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Wells Fargo
Hold9.00+55.17%11.00MaintainMay 07, 2026
Stifel
Hold8.00+37.93%9.00MaintainMay 07, 2026
Needham
Buy11.00+89.66%13.00MaintainMay 07, 2026
Stifel
Hold9.00+55.17%10.00MaintainMar 09, 2026
UBS
Hold9.00+55.17%8.00MaintainFeb 26, 2026

Rxsight Inc Earnings Call Summary for Q1/2026

  • RxSight Q1 2026 EPS of -$0.19 beat forecast of -$0.31; revenue of $30.9M exceeded $29.75M estimate despite 18% YoY decline.
  • Gross margins improved to 76.1% from 74.8% YoY, driven by higher Light Adjustable Lens sales mix; net loss totaled $15.9M.
  • Stock fell 1.93% to $7.12 in aftermarket trading despite earnings beat, down 30% YTD and nearly 48% over past year.
  • Full-year 2026 revenue guidance maintained at $120M-$135M; gross margins expected at 70-72%, operating expenses at high end of $150M-$160M.
  • CEO emphasized re-engagement opportunities with installed base; company investing in global expansion amid competitive pressures from new IOL entrants.
Last Updated: 05/06/2026, 05:28 PM
Read Full Transcript

Earnings

Latest Release
May 06, 2026
EPS / Forecast
-0.19 / -0.31
Revenue / Forecast
30.9M / 29.75M
EPS Revisions
Last 90 days

RXST Income Statement

Compare RXST to Peers and Sector

Metrics to compare
RXST
Peers
Sector
Relationship
P/E Ratio
−5.1x−4.1x−0.6x
PEG Ratio
0.21−0.210.00
Price / Book
0.9x4.3x2.6x
Price / LTM Sales
1.9x3.2x3.2x
Upside (Analyst Target)
32.7%46.5%48.1%
Fair Value Upside
Unlock7.6%5.8%Unlock

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company’s RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
11.17M27.06%75.70M
Other Institutional Investors
25.68M62.23%174.10M
Public Companies & Retail Investors
4.42M10.72%29.98M
Total
41.27M100.00%279.79M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.6.55%2,705,00618,340
The Vanguard Group, Inc.5.40%2,229,53915,116

People Also Watch

9.70
KELYA
-0.92%
8.85
RLJ
+0.80%
5.580
YI
-2.28%
0.795
HIHO
-1.85%

FAQ

What Is the Rxsight (RXST) Stock Price Today?

The Rxsight stock price today is 5.80 USD.

What Stock Exchange Does Rxsight Trade On?

Rxsight is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Rxsight?

The stock symbol for Rxsight is "RXST."

What Is the Rxsight Market Cap?

As of today, Rxsight market cap is 239.34M USD.

What Is Rxsight's Earnings Per Share (TTM)?

The Rxsight EPS (TTM) is -1.14.

When Is the Next Rxsight Earnings Date?

Rxsight will release its next earnings report on Aug 10, 2026.

From a Technical Analysis Perspective, Is RXST a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Rxsight Stock Split?

Rxsight has split 0 times.

How Many Employees Does Rxsight Have?

Rxsight has 461 employees.

What is the current trading status of Rxsight (RXST)?

As of May 08, 2026, Rxsight (RXST) is trading at a price of 5.80 USD, with a previous close of 6.78 USD. The stock has fluctuated within a day range of 5.30 USD to 6.50 USD, while its 52-week range spans from 5.30 USD to 16.74 USD.

What Is Rxsight (RXST) Price Target According to Analysts?

The average 12-month price target for Rxsight is 9.79 USD, with a high estimate of 13 USD and a low estimate of 8 USD. 1 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +68.72% Upside potential.

What Is the RXST Premarket Price?

RXST's last pre-market stock price is 6.35 USD. The pre-market share volume is 1,950.00, and the stock has decreased by -0.43, or -6.34%.

What Is the RXST After Hours Price?

RXST's last after hours stock price is 5.91 USD, the stock has decreased by 0.11, or 1.90%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.